|Articles|November 18, 2003
Corneal collagen crosslinking safely halts keratoconus progression
Crosslinking of corneal collagen by topical treatment with riboflavinand ultraviolet light exposure shows promise as a safe and effective nonsurgicaltreatment for keratoconus, according to data presented by Theo Seiler, MD,PhD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
2
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
3
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
4
Managing Unique Dry Eye Disease Subtypes in Patients
5














































.png)


